These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26445772)

  • 21. Prevalence of O25b-ST131 clone among Escherichia coli strains producing CTX-M-15, CTX-M-14 and CTX-M-92 β-lactamases.
    Giedraitienė A; Vitkauskienė A; Pavilonis A; Patamsytė V; Genel N; Decre D; Arlet G
    Infect Dis (Lond); 2017 Feb; 49(2):106-112. PubMed ID: 27563748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131.
    Dahbi G; Mora A; Mamani R; López C; Alonso MP; Marzoa J; Blanco M; Herrera A; Viso S; García-Garrote F; Tchesnokova V; Billig M; de la Cruz F; de Toro M; González-López JJ; Prats G; Chaves F; Martínez-Martínez L; López-Cerezo L; Denamur E; Blanco J
    Int J Med Microbiol; 2014 Nov; 304(8):1247-57. PubMed ID: 25455219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan.
    Huang IF; Lee WY; Wang JL; Hung CH; Hu HH; Hung WY; Hung YJ; Chen WC; Shen YT; Cheng MF
    BMC Gastroenterol; 2018 Jun; 18(1):86. PubMed ID: 29907090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
    Kim YA; Lee K; Chung JE
    BMC Infect Dis; 2018 Jun; 18(1):250. PubMed ID: 29859045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
    Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
    J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.
    Merino I; Shaw E; Horcajada JP; Cercenado E; Mirelis B; Pallarés MA; Gómez J; Xercavins M; Martínez-Martínez L; De Cueto M; Cantón R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2016 Aug; 71(8):2125-30. PubMed ID: 27494832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.
    Can F; Kurt-Azap Ö; İspir P; Nurtop E; Seref C; Loçlar İ; Aktaş ON; Orhan YC; Ergonul O
    J Glob Antimicrob Resist; 2016 Mar; 4():49-52. PubMed ID: 27436393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
    Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic
    Shaik S; Ranjan A; Tiwari SK; Hussain A; Nandanwar N; Kumar N; Jadhav S; Semmler T; Baddam R; Islam MA; Alam M; Wieler LH; Watanabe H; Ahmed N
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066550
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.
    Johnson JR; Clermont O; Johnston B; Clabots C; Tchesnokova V; Sokurenko E; Junka AF; Maczynska B; Denamur E
    J Clin Microbiol; 2014 May; 52(5):1358-65. PubMed ID: 24501035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
    Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
    Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes.
    Irenge LM; Ambroise J; Bearzatto B; Durant JF; Chirimwami RB; Gala JL
    BMC Infect Dis; 2019 Feb; 19(1):137. PubMed ID: 30744567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Features and Treatment Outcomes of Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.
    Cho SY; Kang CI; Cha MK; Wi YM; Ha YE; Chung DR; Lee NY; Peck KR; Song JH;
    Microb Drug Resist; 2015 Aug; 21(4):463-9. PubMed ID: 25756854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Hastak P; Fourment M; Darling AE; Gottlieb T; Cheong E; Merlino J; Myers GSA; Djordjevic SP; Roy Chowdhury P
    Emerg Microbes Infect; 2020 Dec; 9(1):1780-1792. PubMed ID: 32686595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.
    Kresken M; Pfeifer Y; Hafner D; Wresch R; Körber-Irrgang B;
    Int J Antimicrob Agents; 2014 Oct; 44(4):295-300. PubMed ID: 25223936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.
    Rogers BA; Ingram PR; Runnegar N; Pitman MC; Freeman JT; Athan E; Havers S; Sidjabat HE; Gunning E; De Almeida M; Styles K; Paterson DL;
    Int J Antimicrob Agents; 2015 Apr; 45(4):351-8. PubMed ID: 25707371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.